A Open-Label, Two-sequence Phase I Drug-drug Interaction Clinical Study to Investigate the Pharmacokinetics of Leritrelvir With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin in Healthy Participants
Latest Information Update: 19 Apr 2024
At a glance
- Drugs Leritrelvir (Primary) ; Midazolam; Omeprazole; Rifampicin; Rosuvastatin; Verapamil
- Indications COVID 2019 infections
- Focus Pharmacokinetics
- Sponsors Guangdong Raynovent Biotech
Most Recent Events
- 14 Apr 2024 Status changed from recruiting to completed.
- 20 Nov 2023 Planned End Date changed from 31 Oct 2023 to 31 Dec 2023.
- 20 Nov 2023 Status changed from not yet recruiting to recruiting.